Cadila

Zydus Cadila has received final USFDA approval to market levofloxacin injection, used to treat bacterial infections, in the American market. The drug injection is made […]

Zydus Cadila has received final USFDA approval to market Felbamate tablets, used to treat seizures in people with epilepsy, in the American market. The company […]

Zydus Cadila has received final USFDA approval to market antihistamine Cyproheptadine Hydrochloride tablets in the US market. The tablets are used to relieve allergy symptoms […]

Zydus Cadila has received approval from USFDA to market mesalamine tablets used for the treatment of ulcerative colitis. The US FDA has given its final […]

Zydus Cadila has received USFDA approval to market Mirtazapine orally disintegrating tablets, an anti depressant, in the US market. The drug will be marketed in […]

Zydus Cadila has received final USFDA approval to market Doxazosin tablets, used for treatment of high blood pressure and urinary retention associated with enlargement of […]

Zydus Cadila has received final USFDA approval to market Acylovir drug for injection USP in strengths of 500 mg/vial and 1000 mg/vial. The drug is […]

Zydus Cadila has received final USFDA approval to market oxybutynin chloride tablets in USA. The drug is used to treat overactive bladder and urinary incontinence […]

Zydus Cadila has received final USFDA approval to market fluconazole tablets used for the treatment of fungal infections in USA market. The company also received […]